Your browser doesn't support javascript.
HOLA COVID-19 Study: Evaluating the Impact of Caring for Patients With COVID-19 on Cancer Care Delivery in Latin America.
Bernabe-Ramirez, Carolina; Velazquez, Ana I; Olazagasti, Coral; Decat Bergerot, Cristiane; Bergerot, Paulo Gustavo; Corona Cruz, Jose; Riano, Ivy; Adaniel, Christina; Ramirez, Francisca; Anampa, Jesus; Cajina, Carmen; Mena, Evelin; Gracia, Elias; Menendez, Alvaro; Idrovo, Henry; Bezares, Raimundo; Castillo Fernandez, Omar Orlando; Duque, Liseth; Corrales-Rodríguez, Luis; Ramos, Glenda; Kihn-Alarcón, Alba J; Schlam, Ilana; Bruno, Ximena; Umanzor, Gerardo; Castro, Jenny Lissette; Losco, Federico; Ubillos, Luis; Richardet, Eduardo; Soto-Perez-de-Celis, Enrique; Duma, Narjust.
  • Bernabe-Ramirez C; Essen Health Care, Bronx, NY.
  • Velazquez AI; Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, San Francisco, CA.
  • Olazagasti C; National Clinician Scholars Program, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco, San Francisco, CA.
  • Decat Bergerot C; Sylvester Comprehensive Cancer Center at the University of Miami, Miami, ML.
  • Bergerot PG; Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil.
  • Corona Cruz J; Centro de Câncer de Brasília (CETTRO), Brasília, DF, Brazil.
  • Riano I; Instituto Nacional de Cancerologia (INCan), Mexico City, Mexico.
  • Adaniel C; Hematology and Oncology Section, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
  • Ramirez F; Clinica Alemana, Santiago, Chile.
  • Anampa J; SOLCA, Instituto Oncologico Nacional, Guayaquil, Ecuador.
  • Cajina C; Montefiore Medical Center/Albert Einstein College of Medicine/Albert Einstein Cancer Center, Bronx, NY.
  • Mena E; Universidad Nacional Autonoma de Nicaragua, Managua, Nicaragua.
  • Gracia E; Instituto Nacional Del Cancer Rosa Emilia Sanchez Perez de Tavares (INCART), Santo Domingo, Dominican Republic.
  • Menendez A; National Institute of Oncology and Radiobiology, Havana City, Cuba.
  • Idrovo H; Hartford Healthcare, Hartford, CT.
  • Bezares R; Universidad del Valle, Cali, Colombia.
  • Castillo Fernandez OO; Hospital Teodoro Alvarez Caba, Buenos Aires, Argentina.
  • Duque L; Instituto Oncologico Nacional, Panama City, Panama.
  • Corrales-Rodríguez L; Hospital Universitario Dr Jose Maria Vargas, Caracas, Venezuela.
  • Ramos G; Clinical Oncology Department, Hospital San Juan de Dios, San José, Costa Rica.
  • Kihn-Alarcón AJ; SOLCA, Instituto Oncologico Nacional, Guayaquil, Ecuador.
  • Schlam I; Research Department, Liga Nacional Contra el Cáncer & Instituto de Cancerología, Guatemala City, Guatemala.
  • Bruno X; Tufts Medical Center, Boston, MA.
  • Umanzor G; Hematology Oncology Division, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Castro JL; Centro Oncologico Integral in San Pedro Sula, Honduras.
  • Losco F; Department of Medical Oncology, Oncology Hospital, Salvadoran Institute of Social Security, Rosales National Hospital, San Salvador, El Salvador.
  • Ubillos L; Instituto Alexander Fleming, Ciudad Autónoma de Buenos Aires, Argentina.
  • Richardet E; Hospital de Clínicas, Montevideo, Uruguay.
  • Soto-Perez-de-Celis E; Instituto Oncológico De Córdoba, Córdoba, Argentina.
  • Duma N; Department of Geriatrics, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico.
JCO Glob Oncol ; 8: e2100251, 2022 03.
Article in English | MEDLINE | ID: covidwho-1731565
ABSTRACT

PURPOSE:

The HOLA COVID-19 study sought to evaluate the impact of COVID-19 on oncology practices across Latin America (LATAM), challenges faced by physicians, and how practices and physicians adapted while delivering care to patients with cancer.

METHODS:

This international cross-sectional study of oncology physicians in LATAM included a 43-item anonymous online survey to evaluate changes and adaptations to clinical practice. Multivariable logistic regression analyses were used to evaluate the association of caring for patients with COVID-19 and changes to clinical practice.

RESULTS:

A total of 704 oncology physicians from 19 countries completed the survey. Among respondents, the most common specialty was general oncology (34%) and 56% of physicians had cared for patients with COVID-19. The majority of physicians (70%) noted a decrease in the number of new patients evaluated during the COVID-19 pandemic when compared with prepandemic, and 73% reported adopting the use of telemedicine in their practice. More than half (58%) of physicians reported making changes to the treatments that they offered to patients with cancer. In adjusted models, physicians who had cared for patients with COVID-19 had higher odds of changing the type of chemotherapy or treatments that they offered (adjusted odds ratio 1.81; 95% CI, 1.30 to 2.53) and of delaying chemotherapy start (adjusted odds ratio 2.05; 95% CI, 1.49 to 2.81). Physicians identified significant delays in access to radiation and surgical services, diagnostic tests, and supportive care.

CONCLUSION:

The COVID-19 pandemic has significantly disrupted global cancer care. Although changes to health care delivery are a necessary response to this global crisis, our study highlights the significant disruption and changes to the treatment plans of patients with cancer in LATAM resulting from the COVID-19 health care crisis.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: JCO Glob Oncol Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: JCO Glob Oncol Year: 2022 Document Type: Article